Showing results (1161-1170 of 1,293) with videos related to
Sort By:
Pageof 130
The American Journal of Medicine|April 25, 2024
Long COVID Characteristics and Experience: A Descriptive Study From the Yale LISTEN Research CohortMitsuaki Sawano, Yilun Wu, Rishi M Shah, et al.Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|July 10, 2013
Ecosystem change and stability over multiple decades in the Swedish subarctic: complex processes and multiple driversTerry V Callaghan, Christer Jonasson, Tomas Thierfelder, et al.Rheumatology (Oxford, England)|December 28, 2020
Comparison of treatment retention and response to secukinumab versus tumour necrosis factor inhibitors in psoriatic arthritisUlf Lindström, Bente Glintborg, Daniela Di Giuseppe, et al.Nature Structural & Molecular Biology|December 20, 2016
Crystal structures of human glycine receptor α3 bound to a novel class of analgesic potentiatorsXin Huang, Paul L Shaffer, Shawn Ayube, et al.Scientific Reports|January 26, 2017
Long-term and realistic global change manipulations had low impact on diversity of soil biota in temperate heathlandMartin Holmstrup, Christian Damgaard, Inger K Schmidt, et al.Atherosclerosis|July 31, 2012
Increased levels of the homeostatic chemokine CXCL13 in human atherosclerosis - Potential role in plaque stabilizationLinda M Smedbakken, Bente Halvorsen, Isabelle Daissormont, et al.Plos Medicine|January 16, 2009
HMGB1 mediates endogenous TLR2 activation and brain tumor regressionJames F Curtin, Naiyou Liu, Marianela Candolfi, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 5, 2008
TLR/MyD88 and liver X receptor alpha signaling pathways reciprocally control Chlamydia pneumoniae-induced acceleration of atherosclerosisYoshikazu Naiki, Rosalinda Sorrentino, Michelle H Wong, et al.Cardiovascular Diabetology|October 7, 2025
Real-world cardiovascular effectiveness of sustained glucagon-like peptide 1 GLP-1 receptor agonist usage in type 2 diabetesKathrine Kold Sørensen, Puriya Daniel Würtz Yazdanfard, Bochra Zareini, et al.The New England Journal of Medicine|November 12, 2023
Semaglutide and Cardiovascular Outcomes in Obesity without DiabetesA Michael Lincoff, Kirstine Brown-Frandsen, Helen M Colhoun, et al.Pageof 130